Last reviewed · How we verify
NCT05302739
The Effects of Facial Cooling on Fencing Performance
NA trial testing Facial cooling in Hyperthermia in 10 participants. Status unknown.
31 August 2022
Quick facts
| Lead sponsor | St Mary's University College |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 10 |
| Start date | 20 April 2022 |
| Primary completion | 31 August 2022 |
| Estimated completion | 26 September 2022 |
Drugs / interventions tested
- Facial cooling
Conditions studied
- Hyperthermia — all drugs for Hyperthermia →
Sponsor
St Mary's University College
Who can join
Adults 18 to 60, male only, with Hyperthermia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Fencing competitions can last between nine and eleven hours, during which athletes wear layers of protective equipment that impair evaporative heat transfer and spend a large amount of time at exercise intensities \> 85% maximum heart rate. Fencing performance can potentially contribute to heat stress due to increases in core temperature. Elevated core temperatures could hamper performance, and therefore the implementation of a strategy to reduce core temperature increases could lead to augmented fencing performance. Cooling methods are limited for use between fencing matches and during short breaks within a direct elimination match. Furthermore, due to multiple layers of thick protective equipment cooling method applications are limited primarily to the facial area. A potential cooling strategy, during fencing competition, includes the utilization of a water facial mist spray combined with fanning of the face. Therefore, the aim of this study is to investigate the novel use of facial cooling on core temperature, relevant physiological parameters, perceived exertion and thermal comfort and sensation during a simulated fencing competition performance, in male epee fencers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05302739
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperthermia
Currently open trials in the same condition.
- NCT07510061 — Title: ICARUS - Psycho-physiological Profiling of Low and High Heat-resilient Individuals · NA · recruiting
- NCT06961929 — IEEM-Heat and Heart Failure · NA · recruiting
- NCT06966336 — IEEM- Work:Rest Cycles in Burn Survivors- Humidity · recruiting
- NCT07433036 — The Effectiveness of Emergency Room Protocols for Treating Hyperthermia · NA · recruiting
- NCT06842784 — Impact of Extreme Heat on Myocardial Blood Flow and Flow Reserve in Young and Older Adults · recruiting
Other St Mary's University College trials
Trials by the same sponsor.
- NCT05571475 — The Effects of Simulated Competition on Repeated-sprint Cycling Performance · NA · unknown
- NCT05521386 — The Effects of Caffeine on Heart Rate and Heart Rate Variability · NA · unknown
- NCT05346211 — The Effect of Curcumin Supplementation on Recovery From Exercise-induced Muscle Damage · NA · unknown
- NCT05313932 — The Effects of Sleep Deprivation on Physiological and Perceptual Responses During Exercise · NA · unknown
- NCT05268354 — Modification of Risk Factors Associated With Knee Injury in Netball · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05302739 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St Mary's University College
- Last refreshed: 31 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05302739.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing